Related Experiment Video
Updated: Jan 28, 2026
03:47
Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
Published on: July 12, 2024
1.1K
Hyponatremia in Heart Failure: Pathogenesis and Management
Mario Rodriguez1,2, Marcelo Hernandez1, Wisit Cheungpasitporn3
1Department of Internal Medicine, Icahn School of Medicine at Mount Sinai St' Luke and Mount Sinai West, New York, NY, United States.
Current Cardiology Reviews
|March 8, 2019
Summary
Hyponatremia in heart failure (HF) patients has two causes: fluid overload or diuretic overuse, requiring different treatments. Understanding these distinct mechanisms is key for effective patient management and improved outcomes.
Area of Science:
- Cardiology
- Nephrology
- Endocrinology
Background:
- Hyponatremia is a common complication in heart failure (HF) patients, linked to adverse outcomes.
- It arises from two opposing mechanisms: dilutional hypervolemic hyponatremia due to congestion, and hypovolemic hyponatremia from natriuretic use.
- These distinct pathophysiologies necessitate tailored therapeutic strategies.
Purpose of the Study:
- To review the pathogenesis of hyponatremia in heart failure.
- To summarize current and emerging management strategies for hyponatremia in HF patients.
Main Methods:
- Literature review of studies on hyponatremia in heart failure.
- Analysis of pathophysiological mechanisms including arginine vasopressin (AVP) role.
- Evaluation of therapeutic approaches: fluid restriction, diuretics, AVP antagonists, and hypertonic saline.
Main Results:
- Hypervolemic hyponatremia in HF is often driven by arginine vasopressin (AVP) release due to poor renal perfusion.
- Standard treatments include fluid restriction and loop diuretics for hypervolemic hyponatremia.
- Emerging treatments like AVP antagonists and hypertonic saline show promise.
Conclusions:
- Hyponatremia in HF is complex, with distinct causes requiring individualized treatment.
- Effective management hinges on differentiating between hypervolemic and hypovolemic hyponatremia.
- Further research into novel therapies like AVP antagonists is warranted.
Related Concept Videos
01:30Heart Failure V: Medical Management
267
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
267
01:20Asthma: Pathogenesis and Management
1.3K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.3K
01:17Pathophysiology of Heart Failure
3.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.4K
01:27Heart Failure I: Introduction
829
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
829
01:29Heart Failure II: Pathophysiology
855
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
855
01:22Heart Failure Drugs: Diuretics
935
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
935